Keywords: Targacept, AstraZeneca, AZD1446, ADHD Alzheimer's

Targacept slides as ADHD drug under development with AstraZeneca disappoints in Ph II

Article | 08 October 2010

Print This

Targacept (Nasdaq: TRGT) saw its share fall 5% in pre-market trading yesterday, when the firm revealed that top-line results from a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in